Zimbabwe has declined a substantial American health deal worth $367m (£272m) spanning five years over the United States' insistence on confidential information.
This rejection was revealed after a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official spokesman has since stated that the United States was demanding access to biological samples for scientific study and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged further dialogue to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can continue.
Wider Implications
This rejection comes after a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance openness and accountability.
As per reports, Sixteen African countries have to date agreed to these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Put simply, our country would provide the basic resources for medical research with no certainty that the resulting innovations would be available to our citizens should a new pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining structures already established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a country provides its data, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how future co-operation might be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body stated it acknowledged the government's concerns, but urged that talks must proceed considering a large portion of the nation's Aids initiatives depended on foreign aid.
"If specific concerns exist, such as those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group said.
The halted deal underscores the ongoing debate between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.